Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Vilaprisan for treating uterine fibroids.

Melis GB, Neri M, Piras B, Paoletti AM, Ajossa S, Pilloni M, Marotto MF, Corda V, Saba A, Giancane E, Mais V.

Expert Opin Investig Drugs. 2018 May;27(5):497-505. doi: 10.1080/13543784.2018.1471134. Epub 2018 May 7. Review.

PMID:
29718788
2.

Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.

Liang B, Wu L, Xu H, Cheung CW, Fung WY, Wong SW, Wang CC.

Reprod Biol Endocrinol. 2018 Apr 3;16(1):32. doi: 10.1186/s12958-018-0347-9.

3.

Two synthetic progestins and natural progesterone are responsible for most of the progestagenic activities in municipal wastewater treatment plant effluents in the Czech and Slovak republics.

Šauer P, Stará A, Golovko O, Valentová O, Bořík A, Grabic R, Kroupová HK.

Water Res. 2018 Jun 15;137:64-71. doi: 10.1016/j.watres.2018.02.065. Epub 2018 Mar 2.

PMID:
29544204
4.

Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs.

Badiani B, Chiumente M, Messori A.

Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:84-88. doi: 10.1016/j.ejogrb.2018.01.020. Epub 2018 Feb 3.

PMID:
29408752
5.

Preoperative medical therapy before surgery for uterine fibroids.

Lethaby A, Puscasiu L, Vollenhoven B.

Cochrane Database Syst Rev. 2017 Nov 15;11:CD000547. doi: 10.1002/14651858.CD000547.pub2. Review.

PMID:
29139105
6.

Interventions for emergency contraception.

Shen J, Che Y, Showell E, Chen K, Cheng L.

Cochrane Database Syst Rev. 2017 Aug 2;8:CD001324. doi: 10.1002/14651858.CD001324.pub5. Review.

PMID:
28766313
7.

Progesterone receptor modulators for endometriosis.

Fu J, Song H, Zhou M, Zhu H, Wang Y, Chen H, Huang W.

Cochrane Database Syst Rev. 2017 Jul 25;7:CD009881. doi: 10.1002/14651858.CD009881.pub2. Review.

PMID:
28742263
8.

The safety of available and emerging options for emergency contraception.

Lee JK, Schwarz EB.

Expert Opin Drug Saf. 2017 Oct;16(10):1163-1171. doi: 10.1080/14740338.2017.1354985. Epub 2017 Jul 27. Review.

PMID:
28730840
9.

Quick starting hormonal contraception after using oral emergency contraception: a systematic review.

Murphy LE, Chen ZE, Warner V, Cameron ST.

J Fam Plann Reprod Health Care. 2017 Oct;43(4):319-326. doi: 10.1136/jfprhc-2017-101740. Epub 2017 Jun 29. Review.

PMID:
28663249
10.

Endometrial changes during ulipristal acetate use: A systematic review.

De Milliano I, Van Hattum D, Ket JCF, Huirne JAF, Hehenkamp WJK.

Eur J Obstet Gynecol Reprod Biol. 2017 Jul;214:56-64. doi: 10.1016/j.ejogrb.2017.04.042. Epub 2017 Apr 28. Review.

PMID:
28482329
11.

Ulipristal acetate: An update for Australian GPs.

Mazza D.

Aust Fam Physician. 2017;46(5):301-304.

12.

Selective progesterone receptor modulators (SPRMs) for uterine fibroids.

Murji A, Whitaker L, Chow TL, Sobel ML.

Cochrane Database Syst Rev. 2017 Apr 26;4:CD010770. doi: 10.1002/14651858.CD010770.pub2. Review.

PMID:
28444736
13.

Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment?

Pourcelot AG, Capmas P, Fernandez H.

J Gynecol Obstet Hum Reprod. 2017 Mar;46(3):249-254. doi: 10.1016/j.jogoh.2017.02.001. Epub 2017 Feb 3.

PMID:
28403922
14.

Pregnancy Outcomes Following Ulipristal Acetate Emergency Contraception Failure: A Report of Five Cases.

Ozturk Z, Akgul E.

Fetal Pediatr Pathol. 2017 Jun;36(3):213-219. doi: 10.1080/15513815.2017.1303010. Epub 2017 Apr 3.

PMID:
28368774
15.

Safety after extended repeated use of ulipristal acetate for uterine fibroids.

Fauser BC, Donnez J, Bouchard P, Barlow DH, Vázquez F, Arriagada P, Skouby SO, Palacios S, Tomaszewski J, Lemieszczuk B, William AR.

PLoS One. 2017 Mar 7;12(3):e0173523. doi: 10.1371/journal.pone.0173523. eCollection 2017.

16.

[In process].

Freye R.

Med Monatsschr Pharm. 2016 Dec;39(12):531-5. German. No abstract available.

PMID:
29979517
17.

Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results.

Fernandez H, Schmidt T, Powell M, Costa AP, Arriagada P, Thaler C.

Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:91-96. doi: 10.1016/j.ejogrb.2016.11.003. Epub 2016 Nov 19.

PMID:
27898340
18.

Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.

Donnez J, Donnez O, Dolmans MM.

Expert Opin Drug Saf. 2016 Dec;15(12):1679-1686. Epub 2016 Nov 2. Review.

PMID:
27740868
19.

Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation.

Istre O.

J Minim Invasive Gynecol. 2017 Feb;24(2):198. doi: 10.1016/j.jmig.2016.08.004. Epub 2016 Aug 15.

PMID:
27539216
20.

Role of ethnicity in treating uterine fibroids with ulipristal acetate.

Murji A, Crosier R, Chow T, Ye XY, Shirreff L.

Fertil Steril. 2016 Oct;106(5):1165-1169. doi: 10.1016/j.fertnstert.2016.06.012. Epub 2016 Jun 20.

PMID:
27336213

Supplemental Content

Loading ...
Support Center